{"id":"W2598031041","doi":"10.1093/schbul/sbx021.149","title":"111. Efficacy and Safety of MIN-101: A New Drug for the Treatment of Negative Symptoms in Schizophrenia. A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial","year":2017,"lang":"en","type":"article","venue":"Schizophrenia Bulletin","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Positive and Negative Syndrome Scale; Tolerability; Placebo; Schizophrenia (object-oriented programming); Clinical Global Impression; Internal medicine; Randomized controlled trial; Clinical endpoint; Adverse effect; Psychology; Psychiatry; Repeated measures design; Clinical trial; Medicine; Psychosis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001504764,0.00121736,0.00233119,0.0003931338,0.0003762767,0.0009826509,0.0008157258,0.00230536,0.00909174],"category_scores_gemma":[0.001117371,0.0006552581,0.001260809,0.0003240433,0.0008191328,0.0008930482,0.0003011628,0.00187835,0.001586469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004606154,"about_ca_system_score_gemma":0.0007573997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004797347,"about_ca_topic_score_gemma":0.001037541,"domain_scores_codex":[0.9994948,0.0002703388,0.00005239282,0.00008476333,0.0000428252,0.00005487266],"domain_scores_gemma":[0.9995116,0.0001217472,0.000123468,0.00003365942,0.00003713187,0.000172345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9612263,0.004856127,0.0004424736,0.001245562,0.0005760019,0.00008079651,0.00003913657,0.0002305283,0.005980249,0.0001338713,0.001042919,0.02414587],"study_design_scores_gemma":[0.9428695,0.05435158,0.001172577,0.00004377371,0.000179861,0.00004120651,0.00001021495,0.0002577972,0.0004061223,0.00005409529,0.0006030264,0.00001034285],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9703646,0.01205731,0.001003388,0.001121856,0.0009498257,0.006732334,0.002469275,0.0003038299,0.004997691],"genre_scores_gemma":[0.9733632,0.005476713,0.00242037,0.001957208,0.0005067626,0.00785496,0.002400997,0.00003660579,0.005983268],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00909174,"threshold_uncertainty_score":0.03041488,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02122270088175771,"score_gpt":0.2906111112598571,"score_spread":0.2693884103780994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}